LomustineProcarbazineAntineoplastic Combined Chemotherapy ProtocolsTransplantation, AutologousVincristinePeripheral Blood Stem Cell TransplantationCombined Modality TherapyCyclophosphamideAntineoplastic AgentsHematopoietic Stem Cell TransplantationChemotherapy, AdjuvantTreatment OutcomeDoxorubicinLymphoma, Non-HodgkinSalvage TherapyRadiation DosageCisplatinRadiation, IonizingEtoposideDose-Response Relationship, DrugRadiation InjuriesDisease-Free SurvivalDrug Administration ScheduleDose-Response Relationship, RadiationMethotrexateSurvival AnalysisVinblastineNeoplasm StagingNeoadjuvant TherapySurvival RateBleomycinBreast NeoplasmsPrognosisAntineoplastic Agents, PhytogenicRadiation ToleranceLung NeoplasmsRadiationPaclitaxelRadiotherapyCarboplatinIfosfamideNeoplasm Recurrence, LocalDrug Resistance, NeoplasmRadiotherapy DosageTime FactorsRadiation MonitoringCytarabineNeoplasmsRadiation ProtectionHodgkin DiseaseInduction ChemotherapyFollow-Up StudiesTaxoidsAntineoplastic Agents, AlkylatingRadiotherapy, AdjuvantDacarbazineAntimetabolites, AntineoplasticBrain NeoplasmsDaunorubicinMelphalanOrganoplatinum CompoundsDeoxycytidineAntibiotics, AntineoplasticAntibodies, Monoclonal, Murine-DerivedNeutropeniaCarmustineNeoplasm MetastasisPrecursor Cell Lymphoblastic Leukemia-LymphomaPrednisoloneClinical Trials as TopicProspective StudiesAnthracyclinesAdenocarcinomaCarcinoma, Non-Small-Cell LungP-GlycoproteinInfusions, IntravenousVinca AlkaloidsVomitingRadiation OncologyNauseaCell Line, TumorLymphoma, Large B-Cell, DiffuseTesticular NeoplasmsOvarian NeoplasmsMitoxantroneChemotherapy, Cancer, Regional PerfusionGranulocyte Colony-Stimulating FactorAsparaginaseDrug ResistanceRecurrenceLeukopeniaKaplan-Meier EstimateBone NeoplasmsDrug Resistance, MultipleVindesineDose FractionationLymphomaRadiation PneumonitisCamptothecinDexamethasone